Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Other financing activities (2016 - 2019)

Organogenesis Holdings has reported Other financing activities over the past 4 years, most recently at $2.0 million for Q4 2019.

  • For Q4 2019, Other financing activities changed N/A year-over-year to $2.0 million; the TTM value through Dec 2019 reached $3.0 million, up 1579.66%, while the annual FY2020 figure was $5.7 million, 90.25% up from the prior year.
  • Other financing activities for Q4 2019 was $2.0 million at Organogenesis Holdings, up from $75000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $2.0 million in Q4 2019 and troughed at $9000.0 in Q1 2018.
  • A 4-year average of $405819.9 and a median of $122000.0 in 2018 define the central range for Other financing activities.
  • Biggest five-year swings in Other financing activities: plummeted 97.9% in 2018 and later soared 8911.11% in 2019.
  • Year by year, Other financing activities stood at $294019.0 in 2016, then soared by 94.69% to $572422.0 in 2017, then plummeted by 91.96% to $46000.0 in 2018, then surged by 4354.35% to $2.0 million in 2019.
  • Business Quant data shows Other financing activities for ORGO at $2.0 million in Q4 2019, $75000.0 in Q3 2019, and $38000.0 in Q2 2019.